Enko Stock
Consumer ServicesLooking to sell Enko stock or options?
Enko is a developer of safe and sustainable small molecule technologies aimed at helping farmers protect their crops from pests and diseases. The company's approach leverages Deoxyribonucleic Acid (DNA)-encoded libraries, artificial intelligence, structure-based design, and machine learning to identify and select the most effective treatments for specific targets more quickly and efficiently than traditional research and development methods. This enables farmers to access new tools for growing their crops successfully and sustainably.
Alumni Ventures, Germin8 Ventures, Endeavor8, Bill & Melinda Gates Foundation, Eight Roads, Anterra Capital, The World Economic Forum, Alexandria Venture Investments, Akroyd LLC, Bits x Bites, Finistere Ventures, Connecticut Innovations, Nufarm, Taher Gozal, Rabo Ventures, Novalis LifeSciences.
Collective explained in 2 minutes
Learn how Collective's solutions enable you to manage your risk and maximize your wealth
Our available services for this company
Management Team
Board Members
Enko’s stock FAQs
Enko is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Enko stock. Depending on Enko’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Enko stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Enko stock in two ways. First, Enko employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Enko stock. Note that all transactions in Enko shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Enko stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Enko stock. Typically, shares of private companies like Enko are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jul 2022, Enko is reported to have closed an equity financing in which the investors valued the company at $339M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Enko shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Enko is not currently publicly traded, it does not have a ticker symbol.
Enko has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Enko is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Enko shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
